and other data for a number of reasons, such as keeping FT Sites reliable and secure,
personalising content and ads, providing social media features and to
analyse how our Sites are used.
Hannah Kuchler is the global pharmaceutical editor for the Financial Times. She was part of the FT’s team reporting on the Covid-19 pandemic, which received an honourable mention at the SABEW awards for its coverage.
She was previously the US pharma and biotech correspondent based in New York, where she collaborated with PBS Frontline on a documentary about the opioids crisis, which was nominated for an Emmy and won a Loeb award.
Other roles have included over five years as a technology correspondent covering social media and cyber security in San Francisco.